Replication origin firing capacity indicates ATR inhibitor sensitivity.
Saved in:
| Title: | Replication origin firing capacity indicates ATR inhibitor sensitivity. |
|---|---|
| Authors: | Lumeau A; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK., Pfuderer PL; Department of Pathology, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Centre, Li Ka Shing Centre, Cambridge, UK., Scarth JA; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK., Maniati E; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK., Guscott MA; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK., Shaikh N; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK., Copley FB; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Gerdes H; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK., De Angelis S; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK., Alard EL; Centre for Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Wang J; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK., Cutillas PR; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK., Mardakheh FK; Department of Biochemistry, University of Oxford, Oxford, UK., Boemo MA; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Genetics, University of Cambridge, Cambridge, UK., Forment JV; DDR Biology, Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., McClelland SE; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK. s.mcclelland@qmul.ac.uk. |
| Source: | Nature communications [Nat Commun] 2026 Jun 19. Date of Electronic Publication: 2026 Jun 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42321192 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Replication origin firing capacity indicates ATR inhibitor sensitivity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lumeau+A%22">Lumeau A</searchLink>; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Pfuderer+PL%22">Pfuderer PL</searchLink>; Department of Pathology, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Centre, Li Ka Shing Centre, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Scarth+JA%22">Scarth JA</searchLink>; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Maniati+E%22">Maniati E</searchLink>; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Guscott+MA%22">Guscott MA</searchLink>; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Shaikh+N%22">Shaikh N</searchLink>; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Copley+FB%22">Copley FB</searchLink>; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Gerdes+H%22">Gerdes H</searchLink>; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22De+Angelis+S%22">De Angelis S</searchLink>; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Alard+EL%22">Alard EL</searchLink>; Centre for Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Department of Biochemistry, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Cutillas+PR%22">Cutillas PR</searchLink>; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Mardakheh+FK%22">Mardakheh FK</searchLink>; Department of Biochemistry, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Boemo+MA%22">Boemo MA</searchLink>; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Genetics, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Forment+JV%22">Forment JV</searchLink>; DDR Biology, Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22McClelland+SE%22">McClelland SE</searchLink>; Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK. s.mcclelland@qmul.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 Jun 19. <i>Date of Electronic Publication: </i>2026 Jun 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42321192 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-026-74588-7 Languages: – Code: eng Text: English Titles: – TitleFull: Replication origin firing capacity indicates ATR inhibitor sensitivity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lumeau A – PersonEntity: Name: NameFull: Pfuderer PL – PersonEntity: Name: NameFull: Scarth JA – PersonEntity: Name: NameFull: Maniati E – PersonEntity: Name: NameFull: Guscott MA – PersonEntity: Name: NameFull: Shaikh N – PersonEntity: Name: NameFull: Copley FB – PersonEntity: Name: NameFull: Gerdes H – PersonEntity: Name: NameFull: De Angelis S – PersonEntity: Name: NameFull: Alard EL – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Cutillas PR – PersonEntity: Name: NameFull: Mardakheh FK – PersonEntity: Name: NameFull: Boemo MA – PersonEntity: Name: NameFull: Forment JV – PersonEntity: Name: NameFull: McClelland SE IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 06 Text: 2026 Jun 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2041-1723 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |